SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mitsui & Company makes strategic investment in Avon Organics’ parent company

17 Jan 2013 Evaluate

Japan based Mitsui & Company has made a strategic investment in Avon Organics’ parent company - Arch Pharmalabs (Arch) through a secondary market transaction, whereby the Japanese company has purchased 27.29% equity capital of Arch from private equity investors.

The transaction has been completed on January 16, 2013. Subsequent to which Mitsui & Company’s shareholding in Arch has increased from 4.67% to 31.96%.

Arch presently hold 63.60% equity capital of Avon Organics thereby making it a subsidiary company. However, there is no change envisaged/contemplated in the control and management of Arch Pharmalabs and/or at Avon Organics, pursuant to strategic investment by Mistui & Company in Arch.

Kobo Biotech Share Price

2.58 -0.13 (-4.80%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×